NCT05026164View on ClinicalTrials.gov

Study to Assess the Safety, Tolerability, and Effects of CHI-202 to Support Recovery From Physical Activity

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 13, 2021

Primary Completion Date

February 4, 2022

Study Completion Date

February 4, 2022

Conditions
Delayed Onset Muscle Soreness (DOMS)
Interventions
DIETARY_SUPPLEMENT

CHI-202

Blend of cannabinoids \& other ingredients

DIETARY_SUPPLEMENT

CHI-101

Placebo

Trial Locations (1)

33432

International Society for Sports Nutrition, Boca Raton

All Listed Sponsors
lead

Canopy Growth Corporation

INDUSTRY

NCT05026164 - Study to Assess the Safety, Tolerability, and Effects of CHI-202 to Support Recovery From Physical Activity | Biotech Hunter | Biotech Hunter